01 Jan A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitor
Posted at 00:00h
in
Authored by: Vermeulen Joost N., Meijer Dirk K. F., Over Jan, Lange Joep M. A., Proost Johannes H., Bakker Hester I., Beljaars Leonie, Wit Ferdinand W. N. M., Prins Jan M.
In: ANTIVIRAL THERAPY 12(2), 2007, p.273-278
http://www.ncbi.nlm.nih.gov/pubmed/17503670